Genomic Testing Finds Answers for Many Teens
A Rady Children's Institute study of 177 adolescents reviews rapid genomic testing results from 2021 to 2025.
Updated on Nov. 17, 2026 in Health

Live Poll
Would you want your newborn's genome screened for future diseases?
Researchers at Rady Children's Institute for Genomic Medicine reviewed genomic testing results from 177 adolescents aged 13 to 19 who were tested between 2021 and 2025. Positive findings were reported in 36.2% of patients, while 22% had uncertain results and 41.8% had negative results.
Why it matters
The findings suggest genomic testing can identify actionable conditions in teenagers, especially those referred for cardiac or neurological concerns. Eight of the 64 positive findings would also have qualified for reporting through the BeginNGS newborn screening program, which bears on how early genetic screening could be extended.
The study reviewed 117 patients (66.1%) who received rapid whole-genome sequencing and 60 patients (33.9%) who underwent ultra-rapid sequencing. Cardiac conditions had the highest positive rate at 37.7%, followed by neurological conditions at 35.4%, but the study did not report follow-up on clinical outcomes.
The players
Rady Children's Institute for Genomic Medicine
A San Diego-based research institute that applies genomic medicine to pediatric care and research.
BeginNGS
A newborn genomic screening program that evaluates hundreds of early-onset genetic disorders.
The details
Researchers retrospectively reviewed rapid or ultra-rapid whole-genome sequencing results and compared adolescents' results with the current reporting criteria of the BeginNGS program, which evaluates 507 early-onset disorders. The results were presented at the AMP 2026 Annual Meeting.
Timeline
2021 to 2025: Adolescents underwent clinical genomic testing included in the study.
2026: Results were presented at the AMP 2026 Annual Meeting.
Big Picture
The 36.2% positive yield in this adolescent cohort is more than double the 14.7% molecular diagnostic yield reported by the NYCKidSeq study of adolescents and young adults older than 12. The gap suggests that testing outcomes may depend on the clinical reasons for referral, such as cardiac or neurological concerns.
Parents of teenagers referred for heart or neurological evaluations may ask their clinicians whether genomic testing is appropriate. The study does not establish that testing changes treatment, so families should discuss the potential benefits and uncertainties with their doctor.
The takeaway
Genomic testing identified a clinically relevant result in more than one in three adolescents in this study, with cardiac and neurological referrals showing the highest yields. Clinicians and families can weigh these findings alongside the study's retrospective limits when considering testing.
Further reading
For more on pediatric research, explore Children's Health coverage.
Source note: This article includes information reported by Inside Precision Medicine.
Live Poll
Would you want your newborn's genome screened for future diseases?






